Information Provided By: 
Fly News Breaks for April 26, 2018
LMAT
Apr 26, 2018 | 13:30 EDT
As previously reported, Benchmark analyst Raymond Myers upgraded LeMaitre Vascular to Buy from Hold as he believes the 20% post-earnings selloff in the shares is "excessive." He attributes the Q1 earnings shortfall mainly to sales execution issues and thinks management has already taken the necessary steps to fix the problems, he tells investors. Myers, who sees plans to expand the sales force leading to accelerating revenue growth in 2019, set a $40 price target on LeMaitre shares.
News For LMAT From the Last 2 Days
There are no results for your query LMAT
